64
PharmaEssentia
6446.TW·TWSETaipei TWFounded 2003700 employees
Mid CapbiotechPublicHematology
Platform: Besremi
Market Cap
$3B
All Drugs
3
Clinical Trials
6
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (6446.TW)
Loading 6446.TW stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 644-5754 | 644-5754 | Phase 3 | 2 | CDK4/6 | CeliacCSU | ||
| Teraratamab | 644-6648 | Preclinical | 2 | CD3 | Rett | ||
| Semaosocimab | 644-8226 | Phase 2/3 | 2 | HER2 | PNHDLBCL |
SEC Filings & Financial Documents
SEC filings are not available for TWSE-listed companies.
PharmaEssentia trades on TWSE (TW). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (5)